Antibiotic News and Research

RSS

Antibiotics are drugs used to treat infections caused by bacteria and other microorganisms.

Cubist Pharmaceuticals total net revenues for second-quarter 2010 increase 29%

Cubist Pharmaceuticals, Inc. today announced results for the second quarter ended June 30, 2010.

16 Jul 2010

NovaBay Pharmaceuticals issued Notice of Allowance for broad portfolio of anti-infective compounds

NovaBay Pharmaceuticals, Inc. announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office on a patent application for a broad portfolio of anti-infective compounds, including NVC-612. The patent will broaden protection for NovaBay's first-in-class Aganocide family of compounds, which are designed to fight infections without causing drug resistance.

15 Jul 2010

Insight into inner functional mechanisms of new bacterial infection target

In any battle, sizing up one's opponent is a critical first step. For researchers fighting a bacterial infection, that means assessing every nook and cranny of the malicious microorganism and identifying which ones to attack.

14 Jul 2010

TheraDoc clinical surveillance system helps clinicians reduce catheter-related infections: Study

Hospira, Inc., a leading provider of clinical information and medication delivery technologies, today announced a study showing how the TheraDoc clinical surveillance system helped clinicians at Memorial Hospital Miramar reduce catheter-related infections, which correlated with an increase in infection-control interventions.

14 Jul 2010

Life-or-death 'cell competition' process in mammalian tissue identified

A landmark study by Florida State University biologists, in collaboration with scientists in Britain, is the first to identify a life-or-death "cell competition" process in mammalian tissue that suppresses cancer by causing cancerous cells to kill themselves.

14 Jul 2010

Innocoll submits SPA for phase 3 clinical trial of Cogenzia for adjuvant treatment of infected diabetic foot ulcers

Innocoll, Inc. announced that its wholly-owned subsidiary, Innocoll Technologies Ltd., has submitted a Special Protocol Assessment (SPA) for a proposed phase 3 clinical trial to support the U.S. approval of Cogenzia™: Innocoll's topical antibiotic therapy for the adjuvant treatment of infected diabetic foot ulcers.

13 Jul 2010

Palex to distribute MDI's Detect-Ready MRSA assay in Spain

Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Palex Medical S.A., one of Spain's leading distributors of medical device and diagnostic products to hospitals, today announced that they have entered into an exclusive distribution agreement for MDI's Detect-Ready™ MRSA assay in Spain.

13 Jul 2010

Hospitals adopt advanced computer technology to prevent HAIs

Hospitals that adopt advanced computer technology to identify healthcare-associated infections are more likely to have implemented best practices to prevent such infections, according to research presented today at the 37th Annual Conference and International Meeting of the Association for Professionals in Infection Control and Epidemiology.

13 Jul 2010

Renhuang signs Acquisition Agreement with Forest Bureau

Renhuang Pharmaceuticals, Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines, today announced that on July 8, 2010, the Company signed an Acquisition Agreement with Yichun Red Star Forest Bureau of Heilongjiang Province for indefinite exclusive access to 100,000 acres of wild Siberian Ginseng in Heilongjiang Province.

9 Jul 2010

Medicare agency releases data on hospital performance

MedPage Today: "The public can now review data on the quality of outpatient care provided by individual hospitals at the Centers for Medicare and Medicaid Services' Hospital Compare website. The site previously contained only data on inpatient care quality. All the data are derived from records of Medicare patients treated at more than 3,600 hospitals nationwide."

9 Jul 2010

PharmAthene reports progress in lyophilized rPA anthrax vaccine development program

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that it continues to make solid progress in its lyophilized recombinant Protective Antigen (rPA) anthrax vaccine development program. The Company has recently demonstrated that its lyophilized rPA vaccine candidate is structurally stable and potent at various temperatures up to and including 70 degrees centigrade.

9 Jul 2010

Advanced Life Sciences announces positive results from preclinical studies of Restanza IV

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced positive results from preclinical toxicology and pharmacokinetic studies of an intravenous (IV) formulation of its novel antibiotic, Restanza™ that support its use in a hospital setting.

8 Jul 2010

CF patients recover from exacerbations equally well when treated at home or in hospital: Researchers

Patients with cystic fibrosis recover from exacerbations equally well if they are treated at home or in a hospital, according to researchers from Johns Hopkins University. Furthermore, longer treatment with antibiotics does not appear to offer any additional benefit over shorter courses.

8 Jul 2010

Researchers use nanotechnology to develop advanced wound dressing to detect, treat infection

Researchers are using nanotechnology to develop a medical dressing which will detect and treat infection in wounds. Scientists at the University of Bath and the burns team at the Southwest UK Paediatric Burns Centre at Frenchay Hospital in Bristol are working together with teams across Europe and Australia to create an advanced wound dressing.

8 Jul 2010

Dragon Pharma announces sufficient votes based on receipt of preliminary proxies to approve Merger

Dragon Pharmaceutical Inc. announced that based on the receipt of preliminary proxies, the Company believes that it has sufficient votes to approve the Agreement and Plan of Merger by and among Dragon, Chief Respect Limited, Datong Investment Inc., a subsidiary of Chief Respect Limited, and Mr. Yanlin Han.

8 Jul 2010

PolyMedix receives NIH grant to develop defensin-mimetic antimicrobial compounds for malaria

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has received a grant from the National Institute of Health (NIH) to support the development of defensin-mimetic antimicrobial compounds for the treatment of malaria.

7 Jul 2010

Communication between bacterial species promotes resistance to antibiotics: Study

Ear infections caused by more than one species of bacteria could be more persistent and antibiotic-resistant because one pathogen may be communicating with the other, encouraging it to bolster its defenses. Interrupting or removing that communication could be key to curing these infections. Researchers from Wake Forest University Baptist Medical Center publish their findings today in mBio-, the online open-access journal of the American Society for Microbiology.

7 Jul 2010

EUSA grants Ohara Japanese rights to Erwinase oncology therapy

EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, pain control and critical care, today announced that it has granted the Japanese development and commercialization rights to its oncology therapy Erwinase(R) to Ohara Pharmaceutical Company Limited. The agreement represents the first product partnership EUSA has established in Japan.

6 Jul 2010

MabCent finds extraordinary life forms in the Arctic

During its short existence the Centre on Marine Bioactives and Drug Discovery (MabCent) in Tromsø has analysed some 70,000 fractions of Arctic marine organisms. Patents on two molecules have been applied for and applications for another 20 will soon follow.

3 Jul 2010

Karolinska researchers recommend new routine for protection against infection during PEG

Researchers at Karolinska Institutet recommends a new routine for protection against infection when percutaneous endoscopic gastrostomy (PEG), a tube for feeding directly through the abdominal wall, is surgically inserted in the stomach. The new routine is both simpler and cheaper than the one used today. The method, presented in the British Medical Journal, has been clinically tested on over 200 patients at the Karolinska University Hospital in Solna, Stockholm County, Sweden.

2 Jul 2010

Antibiotic News and Research

Further Reading

Cubist Pharmaceuticals total net revenues for second-quarter 2010 increase 29%

NovaBay Pharmaceuticals issued Notice of Allowance for broad portfolio of anti-infective compounds

Insight into inner functional mechanisms of new bacterial infection target

TheraDoc clinical surveillance system helps clinicians reduce catheter-related infections: Study

Life-or-death 'cell competition' process in mammalian tissue identified

Innocoll submits SPA for phase 3 clinical trial of Cogenzia for adjuvant treatment of infected diabetic foot ulcers

Palex to distribute MDI's Detect-Ready MRSA assay in Spain

Hospitals adopt advanced computer technology to prevent HAIs

Renhuang signs Acquisition Agreement with Forest Bureau

Medicare agency releases data on hospital performance

PharmAthene reports progress in lyophilized rPA anthrax vaccine development program

Advanced Life Sciences announces positive results from preclinical studies of Restanza IV

CF patients recover from exacerbations equally well when treated at home or in hospital: Researchers

Researchers use nanotechnology to develop advanced wound dressing to detect, treat infection

Dragon Pharma announces sufficient votes based on receipt of preliminary proxies to approve Merger

PolyMedix receives NIH grant to develop defensin-mimetic antimicrobial compounds for malaria

Communication between bacterial species promotes resistance to antibiotics: Study

EUSA grants Ohara Japanese rights to Erwinase oncology therapy

MabCent finds extraordinary life forms in the Arctic

Karolinska researchers recommend new routine for protection against infection during PEG

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News